Efficacy of Dupilumab in Asthma: Focus on Early, Progressive, and Long‐Lasting Effects on Small Airways
The data that support the findings of this study are available from the corresponding author upon reasonable request. Table S1: Improvement of whole-breath oscillometric variables from baseline (pre-dupilumab) to 3–6 or 12 months of follow-up, according to different studies performed in asthma. Table S2: Baseline characteristics (secondary analysis, N = 51). Figure S1: Lung Function assessed by spirometry (secondary analysis, N = 51). Figure S2: Biomarkers and clinical outcomes (secondary analysis, N = 51). Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Authors
- Federico Mei (ORCID: https://orcid.org/0000-0003-1887-5377)
- Maria Beatrice Bilò (ORCID: https://orcid.org/0000-0002-9324-6039)
- Gianluca Moroncini (ORCID: https://orcid.org/0000-0002-0380-0105)
- Matteo Martini (ORCID: https://orcid.org/0000-0001-9873-9695)
- Angelica Di Vincenzo (ORCID: https://orcid.org/0000-0003-4389-4967)
- Ilaria Claudi (ORCID: https://orcid.org/0009-0002-6211-8146)
- Maria Giovanna Danieli (ORCID: https://orcid.org/0000-0002-9608-2252)
- Maria Stella Garritani
- Leonardo Antonicelli (ORCID: https://orcid.org/0000-0002-7669-9116)
- Mario Andrea Piga (ORCID: https://orcid.org/0000-0001-8678-1650)
- Maria Chiara Braschi (ORCID: https://orcid.org/0000-0003-4605-287X)
- Marco Gallifuoco
- Giada Torresi
Institutions
- Marche Polytechnic University (IT)
- Ospedali Riuniti di Ancona (IT)
- University of Palermo (IT)
Publication Details
- Journal
- Allergy
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1111/all.70097
- Citations
- 1
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.16